Cancer Stem Cells and Stemness Markers in Oral Squamous Cell Carcinomas

  • Published : 2014.11.06


Head and neck squamous cell carcinoma (HNSCC) is one of the world top ten most common cancers with its highest occurrence in the Indian subcontinent and different aggressive and etiological behavioural patterns. The scenario is only getting worst with the 5 year survival rates dropping to 50%, persistent treatment failures and frequent cases of relapse/recurrence. One of the major reasons for these failures is the presence of cancer stem cells (CSCs), a small population of cancer cells that are highly tumourigenic, capable of self-renewal and have the ability to differentiate into cells that constitute the bulk of tumours. Notably, recent evidence suggests that cancer stem cells are especially resistant to conventional therapy and are the "drivers" of local recurrence and metastatic spread. Specific markers for this population have been investigated in HNSCC in the hope of developing a deeper understanding of their role in oral cancer pathogenesis, elucidating novel biomarkers for early diagnosis and newer therapeutic strategies. This review covers the fundamental relevance of almost all the CSC biomarkers established to date with a special emphasis on their impact in the process of oral tumourigenesis and their potential role in improving the diagnosis, prognosis and treatment of OSCC patients.


  1. Van der Gun BT, Melchers LJ, Ruiters MH, et al (2010). EpCAM in carcinogenesis: the good, the bad or the ugly. Carcinogenesis, 31, 1913-21.
  2. Zhang P, Zhang Y, Mao L, Zhang Z, Chen W (2009). Side population in oral squamous cell carcinoma possesses tumour stem cell phenotypes. Cancer Lett, 277, 227-334.
  3. Zhang Q, Shi S, Yen Y, et al (2010). A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy. Cancer Lett, 289, 151-60.
  4. Vaiphei K, Sinha SK, Kochhar R (2014). Comparative analysis of Oct4 in different histological subtypes of esophageal squamous cell carcinomas in different clinical conditions. Asian Pac J Cancer Prev, 15, 3519-24.
  5. Visvader JE and Lindeman GJ (2008). Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nature Reviews Cancer, 8, 755-68.
  6. Warnakulasuriya S (2009). Global epidemiology of oral and oropharyngeal cancer. Oral Oncol, 45, 309-16.
  7. Von Rahden BHA, Kircher S, Lazariotou M, et al (2011). LgR5 expression and cancer stem cell hypothesis: clue to define the true origin of esophageal adenocarcinomas with and without Barrett's Esophagus?. J Exp Clin Cancer Res, 30, 23.
  8. Vincent-Chong VK, Ismail SM, Rahman ZA, et al (2012). Genome-wide analysis of oral squamous cell carcinomas revealed over expression of ISG15, Nestin and WNT11. Oral Dis, 18, 469-76.
  9. Winter MJ, Nagelkerken B, Mertens AE, et al (2003). Expression of Ep-CAM shifts the state of cadherin-mediated adhesions from strong to weak. Exp. Cell Res, 285, 50-8.
  10. Wang X, Wang Y, Yu L, et al (2010). CSPG4 in cancer: multiple roles. Curr Mol Med, 10, 419-29.
  11. Wu MJ, Jan CI, Tsay YG, et al (2010). Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling. Molecular Cancer, 9, 283.
  12. Wu Y, Wu PY (2009). CD133 as a marker for cancer stem cells: progresses and concerns. Stem Cells Dev, 18, 1127-34.
  13. Yamamoto Y, Sakamoto M, Fujii G, et al (2003). Overexpression of orphan G-protein-coupled receptor, Gpr49, in human hepatocellular carcinomas with b-catenin mutations. Hepatol, 37, 528-33.
  14. Yan M, Yang X, Wang L, et al (2013). Plasma membrane proteomics of tumour spheres identify CD166 as a novel marker for cancer stem-like cells in head and neck squamous cell carcinoma. Mol Cell Proteomics, 12, 3271-84.
  15. Yarnazaki H, Mori T, Yazawa M, et al (2013). Stem cell selfrenewal factors Bmi-1 and HMGA2 in head and neck squamous cell carcinoma: clues for diagnosis. Laboratory Investigations, 93, 1331-8.
  16. Sen S, Sharma S, Gupta A, et al (2011). Molecular characterization of explant cultured human oral mucosal epithelial cells. Invest Ophthalmol Vis Sci, 52, 9548-9554.
  17. Yoon HJ, Hong JS, Shin WJ, et al (2011). The role of Cripto-1 in the tumourigenesis and progression of oral squamous cell carcinoma. Oral Oncol, 47, 1023-31.
  18. Yu Q, Toole BP, Stamenkovic I (1997). Induction of apoptosis of metastatic mammary carcinoma cells invivo by disruption of tumour cell surface CD44 function. J Exp Med, 186, 1985-96.
  19. Yu Q, Stamenkovic I (1999). Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44- mediated tumour invasion. Genes Deve, 13, 35-48.
  20. Shimada Y, Ishii G, Nagai K, et al (2009). Expression of podoplanin, CD44, and p63 in squamous cell carcinoma of the lung. Cancer Sci, 100, 2054-2059.
  21. Shmelkov SV, Butler JM, Hooper AT, et al (2008). CD133 expression is not restricted to stem cells and both CD133+ and CD133- metastatic colon cancer cells initiate tumours. J Clin Invest, 118, 2111-20.
  22. Siu A, Lee C, Dang D, Lee C, Ramos DM (2012). Stem cell markers as predictors of oral cancer invasion. Anticancer Res, 32, 1163-6.
  23. Sterz CM, Kulle C, Dakic B, et al (2010). A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumour and is expressing MMP-9. Oral Oncol, 46, 116-22.
  24. Sun S, Wang Z (2011). Head neck squamous cell carcinoma c- Met+ cells display cancer stem cell properties and are responsible for cisplatin-resistance and metastasis. Int J Cancer, 129, 2337-48.
  25. Sun Y, Han J, Lu Y, Yang X, Fan M (2012). Biological characteristics of a cell subpopulation in tongue squamous cell carcinoma. Oral Diseases, 18, 169-177.
  26. Al-Hajj M, Wicha MS, Benito-Hernandez A (2003). Prospective identification of tumourigenic breast cancer cells. ProcNatlAcadSci USA, 100, 3983-8.
  27. Tabor MH, Clay MR, Owen JH et al (2011). Head and neck cancer stem cells: the side population. Laryngoscope, 121, 527-33.
  28. Tsai LL, Yu CC, and Chang YC (2011). Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma. J Oral Pathol Med, 40, 621-8.
  29. Albert S, Hourseau M, Halimi C, et al (2012). Prognostic value of the chemokine receptor CXCR4 and epithelialto-mesenchymal transition in patients with squamous cell carcinoma of the mobile tongue. Oral Oncol, 48, 1263-71.
  30. Bankovic J, Stojsic J, Jovanovic D, et al (2010). Identification of genes associated with non-small-cell lung cancer promotion and progression. Lung Cancer, 67, 151-9.
  31. Bass AJ, Watanabe H, Mermel CH, et al (2009). SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nature Genetics, 41, 1238-42.
  32. Boldrup L, Coates PJ, Gu X, Nylander K. (2007). Delta Np63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck. J Pathol, 4, 384-391.
  33. Bonner JA, Harari PM, Giralt J, et al (2006). Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med, 354, 567-78.
  34. Bonnet D, Dick JE (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med, 3, 730-7.
  35. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T (2005). Migrating cancer stem cells-an integrated concept of malignant tumour progression. Nature Reviews Cancer, 5, 744-9.
  36. Chen YW, Chen KH, Huang PI, et al (2010). Cucurbitacin I Suppressed stem-like property and enhanced radiationinduced apoptosis in head and neck squamous carcinomaderived CD44+ALDH+ cells. Mol Cancer Ther, 9, 2879-92.
  37. Campoli M, Ferrone S, Wang X (2010). Functional and clinical relevance of chondroitin sulfate proteoglycan 4. Adv Cancer Res, 109, 73-121.
  38. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP (2005). Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer, 114, 806-16.
  39. Chen YC, Chen YW, Hsu HS, et al (2009). Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochem Biophys Res Commun, 385, 307-13.
  40. Chen Z (2009). The cancer stem cell concept in progression of head and neck cancer. J Oncol, 2009, 894064.
  41. Chen H, Zhou L, Dou T, et al (2011). Bmi-1's maintenance of the proliferative capacity of laryngeal cancer stem cells. Head Neck, 33, 1115-25.
  42. Chikamatsu K, Ishii H, Takahashi G, et al (2011). Resistance to apoptosis-inducing stimuli in CD44+ head and neck squamous cell carcinoma cells. Head Neck, 34, 336-343.
  43. Chikamatsu K, Takahashi G, Sakakura K, Ferrone S, Masuyama K. (2011). Immunoregulatory properties of CD44+ cancer stem-like cells in squamous cell carcinoma of the head and neck. Head Neck, 33, 208-15.
  44. Chiou SH, Yu CC, Huang CY, et al (2008). Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high grade oral squamous cell carcinoma. Clin Cancer Res, 14, 4085-95.
  45. Chiou SH, Yu CC, Lo WL, et al (2011). Bmi-1 regulates snail expression and promotes metastasis ability in head and neck squamous cancer-derived ALDH1 positive cells. J Oncol, 609259
  46. Gao Q, Tong W, Luria JS, et al (2010). Effects of bone morphogenetic protein-2 on proliferation and angiogenesis in oral squamous cell carcinoma. Int J Oral Maxillofac Surg, 39, 266-71.
  47. Clay MR, Tabor M, Owen JH, et al (2010). Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck, 32, 1195-201.
  48. Davis SJ, Divi V, Owen JH, et al (2010). Metastatic potential of cancer stem cells in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg, 136, 1260-6.
  49. Facompre N, Nakagawa H, Herlyn M, Basu D (2012). Stem-like cells and therapy resistance in squamous cell carcinomas. AdvPharmacol, 65, 235-265.
  50. Geng S, Guo Y, Wang Q, Li L, Wang J (2013). Cancer stemlike cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma. Arch Dermatol Res, 305, 35-47.
  51. Ginestier C, Hur MH, Charafe-Jauffret E, et al (2007). ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell, 1, 555-67.
  52. Grimm M, Krimmel M, Polligkeit J, et al (2012). ABCB5 expression and cancer stem cell hypothesis in oral squamous cell carcinoma. Eur J Cancer, 48, 3186-97.
  53. Haegebarth A, Clevers H (2009). Wnt signaling, Lgr5, and stem cells in the intestine and skin. Am J Pathol, 174, 715-21.
  54. Hombach-Klonisch S, Paranjothy T, Wiechec E, et al (2008). Cancer stem cells as targets for cancer therapy: selected cancers as examples. Arch ImmunolTherExp (Warsz), 56, 165-80.
  55. Huang C, Zhu Y, Duan GL, et al (2013). Screening for MiRNAs related to laryngeal squamous carcinoma stem cell radiation. Asian Pac J Cancer Prev, 14, 4533-7.
  56. Lapidot T, Sirard C, Vormoor J, et al (1994). A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature, 367, 645-8.
  57. Jeng JH, Wang YJ, Chiang BL, et al (2003). Roles of keratinocyte inflammation in oral cancer: regulating the prostaglandin E2, interleukin-6 and TNF-$\alpha$ production of oral epithelial cells by areca nut extract and arecoline. Carcinogenesis, 24, 1301-15.
  58. Kejner AE, Burch MB, Sweeny L, Rosenthal EL (2013). Bone morphogenetic protein 6 expression in oral cavity squamous cell cancer is associated with bone invasion. Laryngoscope, 123, 3061-5.
  59. Keymoosi H, Gheytanchi E, Asgari M, Shariftabrizi A, Madjd Z (2014). ALDH1 in Combination with CD44 as putative cancer stem cell markers are correlated with poor prognosis in urothelial carcinoma of the urinary bladder. Asian Pac J Cancer Prev, 15, 2013-20.
  60. Lim YC, Oh SY, Cha YY, et al (2011). Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomas. Oral Oncol, 47, 83-91.
  61. Liu W, Feng JQ, Shen XM, et al (2012). Two stem cell markers, ATP-binding cassette, G2 subfamily (ABCG2) and BMI-1, predict the transformation of oral leukoplakia to cancer: a long-term follow-up study. Cancer, 118, 1693-700.
  62. Lu SL, Herrington H and Wang XJ (2006). Mouse models for human head and neck squamous cell carcinomas. Head Neck, 28, 945-54.
  63. Madhira SL, Vemuganti G, Bhaduri A, et al (2008). Culture and characterization of oral mucosal epithelial cells on human amniotic membrane for ocular surface reconstruction. Mol Vis, 14, 189-96.
  64. Madjd Z, Ramezani B, Molanae S, Asadi-Lari M (2012). High expression of stem cell marker ALDH1 is associated with reduced BRCA1 in invasive breast carcinomas. Asian Pac J Cancer Prev, 13, 2973-8.
  65. Mascolo M, GennaroIlardi, Romano MF (2012). Overexpression of chromatin assembly factor-1 p60, poly(ADP-ribose) polymerase 1 and nestin predicts metastasizing behaviour of oral cancer. Histopathology, 61, 1089-105.
  66. Maetzel D, Denzel S, Mack B, et al (2009). Nuclear signalling by tumour-associated antigen EpCAM. Nat. Cell Biol, 11, 162-71.
  67. Major AG, Pitty LP, Farah CS (2013). Cancer stem cell markers in head and neck squamous cell carcinoma. Stem Cells International, 319489.
  68. Mao L, Hong WK, Papadimitrakopoulou VA (2004). Focus on head and neck cancer. Cancer Cell, 5, 311-6.
  69. McCullough MJ, Prasad G, Farah CS (2010). Oral mucosal malignancy and potentially malignant lesions: an update on the epidemiology, risk factors, diagnosis and management. Aust Dent J, 55, 61-65.
  70. Meng X, Wuyi L, Yuhong X, Xinming C (2010). Expression of CXCR4 in oral squamous cell carcinoma: correlations with clinicopathology and pivotal role of proliferation. J Oral Pathol Med, 39, 63-8.
  71. Mishra A, Verma M (2010). Cancer biomarkers: are we ready for the prime time? Cancers, 2, 190-208.
  72. Moral M, Segrelles C, Belen A, et al (2009). Transgenic mice expressing constitutively active akt in oral epithelium validate Klf4 as a potential biomarker of head and neck squamous cell carcinoma. In Vivo, 23, 653-660.
  73. Normanno N, De Luca A, Maiello MR, et al (2004). CRIPTO-1: a novel target for therapeutic intervention in human carcinoma. Int J Oncol, 25, 1013-20.
  74. National Cancer Registry Report 2008.
  75. Nubel T, Preobraschenski J, Tuncay H, et al (2009). Claudin-7 regulates EpCAM-mediated functions in tumour progression. Mol. Cancer Res, 7, 285-99.
  76. Qiao B, Johnson NW, Chen X et al (2011). Disclosure of a stem cell phenotype in an oral squamous cell carcinoma cell line induced by BMP-4 via an epithelial-mesenchymal transition. Oncol Rep, 26, 455-61.
  77. Prince ME, Sivanandan R, Kaczorowski A, et al (2007). Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. ProcNatlAcadSci USA, 104, 973-8.
  78. Prince ME, Ailles LE (2008). Cancer stem cells in head and neck squamous cell cancer. J Clin Oncol, 26, 2871-5.
  79. Poage GM, Christensen BC, Houseman EA, et al (2010) Genetic and epigenetic somatic alterations in head and neck squamous cell carcinomas are globally coordinated but not locally targeted. PLoS ONE, 5, 9651.
  80. Qiao B, Gopalan V, Chen Z et al (2012). Epithelial mesenchymal transition and mesenchymal epithelial transition are essential for the acquisition of stem cell properties in hTERTimmortalised oral epithelial cells. Biol Cell, 8, 476-89.
  81. Qiao B, Chen Z, Hu F, Tao Q, Lam AK. (2013). BMI-1 activation is crucial in hTERT- induced epithelial-mesenchymal transition of oral epithelial cells. Exp Mol Pathol, 1, 57-61.
  82. Radisky DC, LaBarge MA (2008). Epithelial-mesenchymal transition and the stem cell phenotype. Cell Stem Cell, 2, 511-2.
  83. Ravindran G, Devaraj H (2012). Aberrant expression of CD133 and musashi-1 in pre-neoplastic and neoplastic human oral squamous epithelium and their correlation with clinicopathological factors. Head Neck, 34, 1129-35.
  84. Satpute PS, Hazarey V, Ahmed R, Yadav L (2013). Cancer stem cells in head and neck squamous cell carcinoma: a review. Asian Pac J Cancer Prev, 14, 5579-87
  85. Scully C, Bagan J (2009). Oral squamous cell carcinoma overview. Oral Oncology, 45, 301-308.

Cited by

  1. Opportunities and challenges of radiotherapy for treating cancer vol.12, pp.9, 2015,
  2. Outcome of Palliative and Radical Radiotherapy in Patients with Oral Squamous Cell Carcinoma - a Retrospective Study vol.16, pp.16, 2015,
  3. Expression of MAGE-A1-A12 subgroups in the invasive tumor front and tumor center in oral squamous cell carcinoma vol.35, pp.4, 2016,
  4. Role of miRNA dynamics and cytokine profile in governing CD44v6/Nanog/PTEN axis in oral cancer: modulating the master regulators vol.37, pp.11, 2016,
  5. Chemokine (CC motif) ligand 18 upregulates Slug expression to promote stem-cell like features by activating the mammalian target of rapamycin pathway in oral squamous cell carcinoma vol.108, pp.8, 2017,
  6. Prognostic Value of Cancer Stem Cell Markers in Head and Neck Squamous Cell Carcinoma: a Meta-analysis vol.7, pp.2045-2322, 2017,
  7. Expression levels of SOX2, KLF4 and brachyury transcription factors are associated with metastasis and poor prognosis in oral squamous cell carcinoma vol.11, pp.2, 2015,
  8. Differential Expression of Prostaglandin I2 Synthase Associated with Arachidonic Acid Pathway in the Oral Squamous Cell Carcinoma vol.2018, pp.1687-8469, 2018,
  9. The promise of stem cell markers in the diagnosis and therapy of epithelial dysplasia and oral squamous cell carcinoma vol.233, pp.11, 2018,
  10. DSPP-MMP20 gene silencing downregulates cancer stem cell markers in human oral cancer cells vol.23, pp.1, 2018,
  11. Assessment of cellular and serum proteome from tongue squamous cell carcinoma patient lacking addictive proclivities for tobacco, betel nut, and alcohol: Case study vol.119, pp.7, 2018,